150 related articles for article (PubMed ID: 35105882)
1. The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples.
Barrett JE; Herzog C; Jones A; Leavy OC; Evans I; Knapp S; Reisel D; Nazarenko T; Kim YN; Franchi D; Ryan A; Franks J; Bjørge L; Zikan M; Cibula D; Harbeck N; Colombo N; Dudbridge F; Jones L; Sundström K; Dillner J; Rådestad AF; Gemzell-Danielsson K; Pashayan N; Widschwendter M
Nat Commun; 2022 Feb; 13(1):449. PubMed ID: 35105882
[TBL] [Abstract][Full Text] [Related]
2. The DNA methylome of cervical cells can predict the presence of ovarian cancer.
Barrett JE; Jones A; Evans I; Reisel D; Herzog C; Chindera K; Kristiansen M; Leavy OC; Manchanda R; Bjørge L; Zikan M; Cibula D; Widschwendter M
Nat Commun; 2022 Feb; 13(1):448. PubMed ID: 35105887
[TBL] [Abstract][Full Text] [Related]
3. Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.
Böck J; Appenzeller S; Haertle L; Schneider T; Gehrig A; Schröder J; Rost S; Wolf B; Bartram CR; Sutter C; Haaf T
Int J Cancer; 2018 Sep; 143(6):1416-1425. PubMed ID: 29659014
[TBL] [Abstract][Full Text] [Related]
4. Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers.
de Almeida BP; Apolónio JD; Binnie A; Castelo-Branco P
BMC Cancer; 2019 Mar; 19(1):219. PubMed ID: 30866861
[TBL] [Abstract][Full Text] [Related]
5. A methylation signature at the CpG island promoter of estrogen receptor beta (ER-β) in breasts of women may be an early footmark of lack of breastfeeding and nulliparity.
Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Meysamie A; Mansoori Y; Nariman-Saleh-Fam Z; Bastami M; Saadatian Z; Roshan SJ; Bayani N; Tavakkoly-Bazzaz J
Pathol Res Pract; 2021 Feb; 218():153328. PubMed ID: 33422777
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA.
Tang Q; Holland-Letz T; Slynko A; Cuk K; Marme F; Schott S; Heil J; Qu B; Golatta M; Bewerunge-Hudler M; Sutter C; Surowy H; Wappenschmidt B; Schmutzler R; Hoth M; Bugert P; Bartram CR; Sohn C; Schneeweiss A; Yang R; Burwinkel B
Oncotarget; 2016 Sep; 7(39):64191-64202. PubMed ID: 27577081
[TBL] [Abstract][Full Text] [Related]
7. Correlation of Smoking-Associated DNA Methylation Changes in Buccal Cells With DNA Methylation Changes in Epithelial Cancer.
Teschendorff AE; Yang Z; Wong A; Pipinikas CP; Jiao Y; Jones A; Anjum S; Hardy R; Salvesen HB; Thirlwell C; Janes SM; Kuh D; Widschwendter M
JAMA Oncol; 2015 Jul; 1(4):476-85. PubMed ID: 26181258
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock.
Barrett JE; Herzog C; Kim YN; Bartlett TE; Jones A; Evans I; Cibula D; Zikan M; Bjørge L; Harbeck N; Colombo N; Howell SJ; Rådestad AF; Gemzell-Danielsson K; Widschwendter M
Genome Biol; 2022 Feb; 23(1):52. PubMed ID: 35189945
[TBL] [Abstract][Full Text] [Related]
9. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
[TBL] [Abstract][Full Text] [Related]
10.
Lorenzo PM; Izquierdo AG; Diaz-Lagares A; Carreira MC; Macias-Gonzalez M; Sandoval J; Cueva J; Lopez-Lopez R; Casanueva FF; Crujeiras AB
Front Endocrinol (Lausanne); 2020; 11():245. PubMed ID: 32390948
[TBL] [Abstract][Full Text] [Related]
11. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
Ramezani F; Salami S; Omrani MD; Maleki D
Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
[TBL] [Abstract][Full Text] [Related]
12. The WID-EC test for the detection and risk prediction of endometrial cancer.
Barrett JE; Jones A; Evans I; Herzog C; Reisel D; Olaitan A; Mould T; MacDonald N; Doufekas K; Newton C; Crosbie EJ; Bjørge L; Colombo N; Dostalek L; Costas L; Peremiquel-Trillas P; Ponce J; Matias-Guiu X; Zikan M; Cibula D; Wang J; Sundström K; Dillner J; Widschwendter M
Int J Cancer; 2023 May; 152(9):1977-1988. PubMed ID: 36533702
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Changes of the ESR1 Gene in Breast Tissue of Healthy Women: A Missing Link with Breast Cancer Risk Factors?
Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Younosi N; Meysamie A; Mansoori Y; Bastami M; Tavakkoly-Bazzaz J
Genet Test Mol Biomarkers; 2017 Aug; 21(8):464-470. PubMed ID: 28708432
[TBL] [Abstract][Full Text] [Related]
14. Detection of epigenetic field defects using a weighted epigenetic distance-based method.
Wang Y; Qian M; Ruan P; Teschendorff AE; Wang S
Nucleic Acids Res; 2019 Jan; 47(1):e6. PubMed ID: 30304472
[TBL] [Abstract][Full Text] [Related]
15. Methylome and transcriptome analyses reveal insights into the epigenetic basis for the good survival of hypomethylated ER-positive breast cancer subtype.
Chen XQ; Zhang F; Su QC; Zeng C; Xiao FH; Peng Y
Clin Epigenetics; 2020 Jan; 12(1):16. PubMed ID: 31959227
[TBL] [Abstract][Full Text] [Related]
16. Methylation of progesterone receptor isoform A promoter in normal breast tissue: An epigenetic link between early age at menarche and risk of breast cancer?
Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Younosi N; Meysamie A; Mansoori Y; Nariman-Saleh-Fam Z; Bastami M; Saadatian Z; Zendehbad Z; Tavakkoly-Bazzaz J
J Cell Biochem; 2019 Aug; 120(8):12393-12401. PubMed ID: 30816620
[TBL] [Abstract][Full Text] [Related]
17. Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer.
Severi G; Southey MC; English DR; Jung CH; Lonie A; McLean C; Tsimiklis H; Hopper JL; Giles GG; Baglietto L
Breast Cancer Res Treat; 2014 Dec; 148(3):665-73. PubMed ID: 25407397
[TBL] [Abstract][Full Text] [Related]
18. CpG methylation signature predicts prognosis in breast cancer.
Du T; Liu B; Wang Z; Wan X; Wu Y
Breast Cancer Res Treat; 2019 Dec; 178(3):565-572. PubMed ID: 31520283
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation signatures to predict the cervicovaginal microbiome status.
Nené NR; Barrett J; Jones A; Evans I; Reisel D; Timms JF; Paprotka T; Leimbach A; Franchi D; Colombo N; Bjørge L; Zikan M; Cibula D; Widschwendter M
Clin Epigenetics; 2020 Nov; 12(1):180. PubMed ID: 33228781
[TBL] [Abstract][Full Text] [Related]
20. Blood DNA Methylation and Breast Cancer: A Prospective Case-Cohort Analysis in the Sister Study.
Xu Z; Sandler DP; Taylor JA
J Natl Cancer Inst; 2020 Jan; 112(1):87-94. PubMed ID: 30989176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
